Ginkgolic acid and anacardic acid are reversible inhibitors of SARS-CoV-2 3-chymotrypsin-like protease

Because of the emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in different regions of the world, the battle with infectious coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has been seesawing. Therefore, the identification of antiviral drugs is of particula...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Dongsheng, Yan, Gangan, Zhou, Wenwen, Si, Shuyi, Liu, Xiaoping, Zhang, Jing, Li, Yan, Chen, Yunyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118179/
https://www.ncbi.nlm.nih.gov/pubmed/35590420
http://dx.doi.org/10.1186/s13578-022-00806-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118179/
https://www.ncbi.nlm.nih.gov/pubmed/35590420
http://dx.doi.org/10.1186/s13578-022-00806-6

Ejemplares similares